Diabetes Mellitus and Pancreatic Ductal Adenocarcinoma—Prevalence, Clinicopathological Variables, and Clinical Outcomes
Background: pancreatic ductal adenocarcinoma (PDAC) is the seventh leading cause of cancer-related deaths with increasing incidence and link to the onset of diabetes mellitus (DM). The aim of this study is to describe the prevalence of DM among patients with the diagnosis of PDAC, analyse the associ...
Main Authors: | Anna Badowska-Kozakiewicz, Marta Fudalej, Daria Kwaśniewska, Marek Durlik, Anna Nasierowska-Guttmejer, Agata Mormul, Emilia Włoszek, Aleksandra Czerw, Tomasz Banaś, Andrzej Deptała |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-06-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/14/12/2840 |
Similar Items
-
Rare Non-Neuroendocrine Pancreatic Tumours
by: Agata Mormul, et al.
Published: (2023-04-01) -
New Treatment Options in Metastatic Pancreatic Cancer
by: Marta Fudalej, et al.
Published: (2023-04-01) -
How A Patient with Resectable or Borderline Resectable Pancreatic Cancer should Be Treated—A Comprehensive Review
by: Daria Kwaśniewska, et al.
Published: (2023-08-01) -
Evaluation of Nutritional Status and the Impact of Nutritional Treatment in Patients with Pancreatic Cancer
by: Dominika Mękal, et al.
Published: (2023-07-01) -
Clinicopathological factors associated with novel prognostic markers for patients with triple negative breast cancer
by: Anna Badowska-Kozakiewicz, et al.
Published: (2018-11-01)